Sign in Pull a receipt

MTNB

Matinas BioPharma Holdings, Inc.

Healthcare · Biotechnology

$306.85 sample

-1.16 (-0.38%) 1D

Market cap

$1.85T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-26

Alerts

8

Price$306.85 +9.53% 3M daily closessample

308.01278.61

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26SECDEF 14A filed
Oct 21SEC10-Q filed
Oct 12INSInsider sell: Director
Oct 05SECForm 144 filed
Sep 24INSInsider sell: Chief Financial Officer
Sep 17INSInsider sell: 10% owner
Sep 08INSInsider sell: EVP, Operations
Aug 28SECDEF 14A filed

Sign up to see the real MTNB record →

Company facts

SEC EDGAR registration

Name: Matinas BioPharma Holdings, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +2sample, -100 to +100
Reporting currency: USD

Who is positioning in MTNB

sample

Insiders: 16 insider transactions over 90 days, net selling, $556.6M
Congress: No member trades over 90 days
Institutions · 13F: 31 funds hold $41.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$117.3B +19.0% y/y

Q4 2024Q3 2026

Inventory$65.8B +7.3% y/y

Q4 2024Q3 2026

Accounts receivable$49.0B +6.6% y/y

Q4 2024Q3 2026

Total debt$131.7B +13.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.26T +0.7% 3M
Sample peer B: $431.7B -4.0% 3M
Sample peer C: $728.4B -5.8% 3M
Sample peer D: $298.3B -0.3% 3M
Sample peer E: $1.67T +3.2% 3M